Cite
HARVARD Citation
Manwani, R. et al. (2019). Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. British journal of haematology. pp. 638-641. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Manwani, R. et al. (2019). Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. British journal of haematology. pp. 638-641. [Online].